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Abstract
OBJECTIVE—Little is known about whether those performing healthcare-associated infection 
(HAI) surveillance vary in their interpretations of HAI definitions developed by the Centers for 
Disease Control and Prevention’s National Healthcare Safety Network (NHSN). Our primary 
objective was to characterize variations in these interpretations using clinical vignettes. We also 
describe predictors of variation in responses.
DESIGN—Cross-sectional study.
SETTING—United States.
PARTICIPANTS—A sample of US-based members of the Society for Healthcare Epidemiology 
of America (SHEA) Research Network.
METHODS—Respondents assessed whether each of 6 clinical vignettes met criteria for an 
NHSN-defined HAI. Individual- and institutional-level data were also gathered.
RESULTS—Surveys were distributed to 143 SHEA Research Network members from 126 
hospitals. In total, 113 responses were obtained, representing at least 61 unique hospitals (30 
respondents did not identify a hospital); 79.2% (84 of 106 nonmissing responses) were infection 
preventionists, and 79.4% (81 of 102 nonmissing responses) worked at academic hospitals. 
Among the 6 vignettes, the proportion of respondents correctly characterizing the vignettes was as 
low as 27.3%. Combining all 6 vignettes, the mean percentage of correct responses was 61.1% 
(95% confidence interval, 57.7%–63.8%). Percentage of correct responses was associated with 
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presence of a clinical background (ie, nursing or physician degrees) but not with hospital size or 
infection prevention and control department characteristics.
CONCLUSIONS—Substantial heterogeneity exists in the application of HAI definitions in this 
survey of infection preventionists and hospital epidemiologists. Our data suggest a need to better 
clarify these definitions, especially when comparing HAI rates across institutions.
Healthcare-associated infections (HAIs) are a leading cause of morbidity and mortality in 
the United States.1–3 Many states now mandate public reporting of HAIs. The Centers for 
Medicare and Medicaid Services (CMS) is halting reimbursement for certain HAIs4 and is 
using improvements in rates of HAIs in determining hospital payments.4,5 There is evidence 
that the increased scrutiny has lowered HAI rates, particularly of central line–associated 
bloodstream infections (CLABSIs) in intensive care units (ICUs).6 Given the potential 
impact on reputation and reimbursement, reliable reporting of HAIs is critical for hospitals, 
payers, and the public.
In many states, HAIs are reportable through the Centers for Disease Control and 
Prevention’s (CDC’s) National Healthcare Surveillance Network (NHSN), which develops 
surveillance definitions.7 Chart review by infection preventionists (IPs) and hospital 
epidemiologists is the standard to which other HAI surveillance methods are compared.8,9 
However, individuals may differ in what they report as HAIs. Researchers have also showed 
only low to moderate interrater agreement between reported cases and outside review.10–13
It is unclear how much of this discrepancy is related to pressure to improve hospital HAI 
rates, differences in interpretations of NHSN definitions, or other factors. Surveys have 
suggested that IPs working in pediatric ICUs may be unclear about NHSN CLABSI 
definitions,14 and some researchers have considered the lack of objectivity in the definition 
of ventilator-associated pneumonia (VAP) as so problematic that they have proposed a more 
streamlined definition.15,16
Little research has been done on interpretations of HAI definitions, and most has focused on 
CLABSI and VAP. Most research to date has been conducted in just one center, healthcare 
system, state, or region. Very little is known about how those working in hospital settings 
across the United States—and therefore subject to changes in CMS reimbursement4,5,17—
interpret NHSN definitions. Furthermore, to our knowledge no study investigating those 
performing HAI surveillance has examined the relationships between differences in 
professional background or work environment characteristics and the interpretation of 
NHSN definitions.
We conducted a cross-sectional study of those performing HAI surveillance at member 
hospitals of the Society for Healthcare Epidemiology of America (SHEA) Research 
Network.18 We used clinical vignettes to investigate variations in interpretations of NHSN 
HAI definitions among those performing HAI surveillance at US hospitals. We also 
investigated whether differences in hospital characteristics, infection prevention and control 
departments, and professional backgrounds are associated with differing interpretations of 
NHSN HAI definitions.
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A questionnaire consisting of 6 clinical vignettes was created to address specific HAIs. Each 
question consisted of a clinical case, and respondents were asked whether each fulfilled 
NHSN criteria for a particular HAI. Questions contained relevant clinical and microbiologic 
information needed for assessment.
Initially, 10 potential vignettes and their answers were reviewed by 3 hospital 
epidemiologists at the University of Pennsylvania and validated by consensus expert review 
by 2 NHSN surveillance experts involved in developing the criteria.7 NHSN expert 
responses were considered the gold standard comparator. Vignettes and other study 
questions were then piloted with 10 IPs. On the basis of their responses, we decreased the 
length of the survey by removing 4 clinical vignettes and edited demographic questions for 
clarity. Clinical vignettes were chosen for removal on the basis of pilot group concerns 
about clarity.
Two questions addressing potential CLABSIs were designed: one met NHSN criteria, and 
the other did not. One item fulfilled NHSN criteria for tracheobronchitis, and another 
fulfilled NHSN criteria for a healthcare-associated Clostridium difficile infection. An item 
addressing a potential VAP was designed to not fulfill NHSN criteria. All pilot group 
respondents answered this VAP question correctly, so this was considered a negative control 
(ie, to ensure that participants were not selecting yes without reading items). Similarly, an 
item designed to fulfill NHSN criteria for an organ space/surgical site infection was 
answered correctly by all pilot group participants and was maintained as a positive control 
(ie, to ensure that participants were not selecting no without reading items). The positive and 
negative control items were designed to be easily and clearly answered correctly by 
respondents. The electronic survey was created using SurveyMonkey (http://
www.surveymonkey.com/; Appendix).
Additional items addressed the respondents’ professional background (job title, time 
working in infection prevention, degrees obtained, and presence of a Certification in 
Infection Control [CIC] credential), infection prevention and control department 
characteristics (size of the department and whether the state mandates HAI reporting), and 
hospital characteristics (size, funding status, whether it is a teaching facility, acute care 
status, and state). Respondents with clinical backgrounds were those who had or were in 
training for an MD, DO, RN, MSN, BSN, LPN, PA, or NP degree. The presence of state-
mandated HAI reporting was self-reported separately for each HAI. For those whose states 
did not currently mandate HAI reporting, participants were asked whether their state was 
planning to do so. With the exception of the hospital name, all items required participants to 
select a response from a list of options.
Study Population
Eligible participants performed HAI surveillance at adult US hospitals in the SHEA 
Research Network.19 Surveys were distributed to 143 SHEA Research Network contacts via 
an e-mailed link on February 1, 2012. Contacts were asked to distribute the surveys to those 
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performing surveillance in their hospitals. Electronic reminders were e-mailed to contacts 2 
and 6 weeks after the initial request. Responses were collected through March 30, 2012. 
Anonymity of healthcare facilities was maintained by removal of the hospital name from the 
data after linking responses from the same hospital. Eligible respondents used NHSN criteria 
for reporting HAIs. While the survey was distributed to those working at non-pediatric US 
hospitals, those who later indicated that they worked at pediatric hospitals or outside the 
United States were excluded. The study was approved by the Institutional Review Board of 
the University of Pennsylvania.
Statistical Analyses
Answers to each clinical vignette were compared for their concordance with NHSN expert 
responses. Descriptive statistics showed percentages of respondents marking correct 
responses to each vignette, as well as mean respondent scores overall. Free-marginal κ 
scores were also calculated with and without the control items.
Negative binomial models were chosen to describe relationships between the percentage of 
correct responses (operationalized as the number of correct responses, with the total number 
of potential responses as an exposure variable) with the presence of a clinical background; 
attaining a CIC credential; length of time in infection prevention; number of people in the 
infection prevention and control department; and hospital size, funding source, and teaching 
status. Analyses were also adjusted for the size of the infection prevention and control 
department and the presence of or plans for state-mandated reporting. Size of the infection 
control and prevention department was a priori dichotomized as less than 5 or at least 5 
members, years in infection prevention was a priori dichotomized as less than 5 and at least 
5, and the hospital size was a priori dichotomized as less than 500 or at least 500 beds. For 
univariate statistics, analysis of variance or χ2 tests were performed as appropriate. Analyses 
were considered significant at α < .05.
For multivariate analyses, those whose states currently or were planning to mandate HAI 
reporting were considered to have mandated reporting. Analyses were performed to explore 
whether mandated reporting of a particular HAI affected responses to questions involving 
that particular HAI. Analyses were also performed for clustering between hospitals. 
Analyses were performed using Stata, version 12.1 (StataCorp).
RESULTS
Surveys were distributed to 143 SHEA Research Network members from 126 hospitals. In 
total, 113 responses were obtained, representing 61 unique hospitals (30 respondents did not 
name their hospital). Assuming that the number of respondents not identifying a hospital had 
a percentage of unique hospitals similar to that among those who did identify their hospital, 
an additional 22 hospitals would be obtained, giving a hospital response rate of 65.9%.
Of the respondents, 79.2% (84 of 106 nonmissing responses) were IPs, with a mean length 
of employment in infection prevention of 11.9 years (Table 1). Eighty-one participants 
(75.7% of 107 nonmissing responses) had a clinical background. Most respondents worked 
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at large acute care academic hospitals. Eighty-nine respondents (78.8% of 108 nonmissing 
responses) worked in states mandating HAI reporting.
Regarding the 6 vignettes, 97.2% (106 of 109 nonmissing responses) of respondents 
correctly answered the negative control question, and 97.3% (108 of 111 nonmissing 
responses) correctly answered the positive control question. Percentage of correct answers 
for the other items ranged from 87.5% (98 of 112 nonmissing responses for an item 
involving a CLABSI) to 27.4% (29 of 106 nonmissing responses for an item involving C. 
difficile). The mean percentage of correct responses (out of 6) was 61.1% (standard 
deviation, 0.96%; Table 2). The free-marginal κ score over all 6 items was 0.51. If the 
positive and negative controls were removed, the free-marginal κ score decreased to 0.32.
In unadjusted analyses, number of correct responses was not associated with being an IP, 
clinical background, hospital size, infection prevention and control department size, or 
length of time in infection prevention (Table 3). In multivariate analyses, when adjusted for 
individual and hospital characteristics, percentage of correct responses was not associated 
with being an IP, years in infection prevention, presence of a CIC credential, presence of 
state-mandated reporting, hospital size, or infection prevention and control department size 
(Table 3). However, having a clinical background was associated with answering more 
questions correctly (adjusted P = .044). There was no association between state-mandated 
reporting of a particular HAI and the likelihood of correctly characterizing a related clinical 
vignette (Table 4).
Of those who gave the name of their hospital, most (47 [74.6%]) were the only respondents 
from their hospital. Other hospitals had between 2 and 5 respondents. Percentage of correct 
responses per hospital did not differ significantly from the study population overall (data not 
shown). Within individual hospitals, percentage of correct responses varied among 
respondents.
Analyses were performed to determine whether participants who did not name their hospital 
differed from those who did. Those who named their hospital had a higher percentage of 
correct responses (P = .022). The mean number of correct responses for those who named 
their hospital was 3.8 (95% confidence interval [CI], 3.6–4.0) of 6, or 63.3%. The mean 
number of correct responses among those who did not name their hospital was 3.3 (95% CI, 
2.8–3.8) of 6, or 55.0%. There were no significant differences in infection prevention and 
control department characteristics, hospital characteristics, or professional background 
between those who did and did not name their hospitals.
Analyses also determined the effect of removing the tracheobronchitis item (which is 
uncommonly targeted in hospital surveillance) from the results. Without this item, the mean 
number of correct responses was 2.91 (95% CI, 2.76–3.07) of 5, or 58.2%, which was not 
significantly different. The free-marginal κ score in the absence of the tracheobronchitis 
item over the 5 remaining items was not significantly different (0.50). When the 
tracheobronchitis item and the positive and negative controls were removed, the free-
marginal κ score decreased to 0.24.
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By studying how those performing HAI surveillance in hospitals across the United States 
apply NHSN HAI definitions to clinical vignettes, we sought to model whether variation in 
interpretations of definitions may exist. While the majority of the respondents correctly 
identified a positive control as an HAI and a negative control as a non-HAI, rates of 
respondents correctly identifying other HAIs ranged from a high of 87.5% to a low of 
27.4%. The mean percentage of correct responses on the survey was low (61.1%), and 
interrater reliability was also low between respondents (κ = 0.32, after excluding the control 
items). The overall percentage of correct responses and overall interrater reliability may be 
low enough to raise doubts about agreement between those performing HAI surveillance. 
Presence of a clinical background was the only characteristic identified as associated with 
more correct responses to survey questions. Research should focus on improving accuracy 
and reliability in applying HAI surveillance criteria.
Prior studies looking at the reproducibility of NHSN HAI criteria have focused on just one 
type of HAI, typically CLABSI or VAP.10–12,14–16 We included items about not just 
CLABSI and VAP but also C. difficile, tracheobronchitis, and organ space/surgical site 
infection. Some have focused on the experiences of reporting HAIs in just one 
state10,11,13,20 or in a few academic medical centers.15,16 We looked at reporting from 28 
different states. No studies before ours have included information about respondent 
workplaces or their training. In addition, 17.9% of our respondents were hospital 
epidemiologists, a group in which HAI interpretation concordance has not been well studied. 
While our study was not powered to explore differences between hospital epidemiologist 
and IP responses to HAI items, we did not see a significant difference in the number of 
correct responses. Understanding hospital epidemiologist HAI reporting is important and 
should be an area of future research, as in many hospitals both hospital epidemiologists and 
IPs discuss reporting of particular HAIs.21
The mean percentage of correct responses on the survey was 61.1%, similar to the 57.1% 
concordance with NHSN experts seen in a survey investigating CLABSI cases in 18 
Australian hospitals.11 Our findings are also similar to a survey of IPs in 10 pediatric ICUs, 
in which all would have named at least one CLABSI in a manner inconsistent with NHSN 
definitions.14
In this study, interrater reliability was lower than that seen between CLABSIs reported by 44 
Oregon hospitals versus those identified by state health officials (κ = 0.32 vs κ = 0.77)13 but 
was similar to that seen between CLABSIs reported by Australian hospitals versus those 
identified by central health officials (κ = 0.31)10 and between CLABSIs categorized by 
Veterans Affairs IPs (κ = 0.42).12 While precise comparisons are difficult given that these 
prior studies focused just on CLABSIs, involved actual patient data, and used different 
scenarios, the data suggest only low to moderate agreement among those performing HAI 
surveillance. Prior studies have suggested that some may overreport infections,22 while 
others may feel pressure to underreport HAIs by their place of employment.19 Outside 
experts may find more HAIs than were reported.20,23 In this study, however, with no 
consequence to their answers, participants likely felt little external pressure to report or not 
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report certain HAIs. Our study may present a more accurate depiction of respondent 
understanding of NHSN definitions.
Two items had particularly low percentages of correct responses. First, only 27.4% of 
participants correctly reported that a clinical vignette did not meet criteria for a healthcare-
associated C. difficile infection. Respondents may have struggled with the multiple infection 
sources in the scenario. Second, only 57.1% of respondents correctly identified that a 
potential CLABSI, in reality a secondary bloodstream infection from a surgical site 
infection, should not be reported. Others have commented on the difficulty in identifying 
NHSN-defined CLABSIs in the presence of other potential infections.14,21 HAI definitions 
in the presence of more than one potential source of infection may require further 
clarification.
We did not identify differences in HAI reporting characteristics based on state-mandated 
reporting requirements, hospital characteristics, or characteristics of infection prevention and 
control departments, although those with a clinical background were more likely to achieve 
higher scores. Unfortunately, it is unclear how to improve the interobserver reliability of 
HAI surveillance. Further studies are first needed to understand what affects the application 
of HAI criteria.
Problems with standardization of HAI definitions are becoming more apparent. For 
example, members of the CDC’s Prevention Epicenters Program are considering criteria for 
ventilator-associated events as a replacement for VAP.15,16,24 Others are trialing electronic 
surveillance systems for HAIs.25–33 A recent study comparing interrater reliability between 
IPs at Veterans Affairs hospitals and through a laboratory-based algorithm actually found a 
higher concordance between IPs and the algorithm than among IPs.12 Efforts such as these 
should continue.
Our study also offers an example of the use of a powerful new research tool for healthcare 
epidemiology, the SHEA Research Network. Prior studies using this resource have included 
a survey of influenza epidemic preparedness34 and a retrospective multicenter cohort study 
of member hospitals on the effect of CMS catheter-associated urinary tract infection 
reimbursement rule changes on antimicrobial prescribing practices.35 Future studies in 
healthcare epidemiology could continue to take advantage of this research consortium.
Our study has some potential limitations. The study population may not represent all those 
performing surveillance. To ensure that we were capturing those who may be affected by 
changes in CMS reimbursements,4,5,17 we focused on US hospitals that used NHSN criteria 
to report HAIs. Our results may not be applicable to those who work outside the United 
States or do not use NHSN criteria. Furthermore, we excluded those working at pediatric-
only hospitals, so results may not apply to those performing surveillance in pediatric 
hospitals. In addition, some of our respondents came from the same hospital. However, the 
bias this would have created would have been toward the null; that is, the actual variation 
between those performing surveillance may have been even higher.
We used hospitals enrolled in the SHEA Research Network for our survey so as to reach 
hospitals in different states. However, those performing HAI surveillance in the SHEA 
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Research Network may not represent all those performing HAI surveillance. Hospitals in the 
SHEA Research Network are more likely than other hospitals to be larger, to be academic, 
and to have more members in their infection prevention and control departments.18
Finally, decision making in this survey may not apply to real-world situations. Reading a 
short paragraph to determine the presence of an HAI is not the same as a thorough chart 
review. Responding anonymously to a clinical vignette is not the same as making a decision 
with potential consequences to the hospital, clinician, and patient. Responses to our survey 
may not precisely match behavior, although we did seek feedback to make vignettes as 
realistic as possible. In addition, to decrease the length of the survey we included only a 
small number of vignettes, which may not be completely representative of all HAIs.
We showed low interrater reliability between those performing HAI surveillance in our 
study. Rates this discordant in practice could dramatically affect not only hospital 
reputations but also hospital reimbursement in the Value-Based Purchasing Program.4,5,17 
Prior to the implementation of CMS HAI reimbursement changes, more reproducible 
definitions of HAIs—or even new approaches to HAI surveillance, such as electronic 
surveillance—are urgently needed.
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APPENDIX. CLINICAL VIGNETTES DISTRIBUTED WITH THE SURVEY
Scenario 1
A 60-year-old patient with acute myeloid leukemia (AML) has been on the oncology floor 
for the last 2 weeks while receiving chemotherapy. He now has an absolute neutrophil count 
of 0 cells/μL. He spikes a fever to 38.5° centigrade (101.3° Fahrenheit). Blood cultures are 
sent, as well as a urinalysis with urine culture. He has no abdominal pain, diarrhea, or 
vomiting but was complaining of nausea on the day of the fever. He has a peripherally 
inserted central catheter (PICC) through which he gets chemotherapy. Urinalysis and urine 
culture are negative. Two out of 4 blood culture bottles sent (1 from each set of 2 blood 
culture bottles) grow Enterococcus.
Does he have an NHSN-defined CLABSI?
A. Yes
B. No
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A 65-year-old woman is intubated prior to a repair of an ascending aortic aneurysm and 
receives 30 units of blood products during the procedure. After the procedure, she is taken to 
the intensive care unit. She remains ventilated. On post-op day 3, she has minimal secretions 
from her endotracheal tube and she is afebrile, but she also has an elevated white blood cell 
count of 16. Her chest X-ray reads “bilateral interstitial infiltrates, consistent with 
pulmonary edema or atelectasis. Pneumonia cannot be ruled out.” Blood cultures are 
negative, urinalysis is negative, she has no diarrhea, and the surgical site is healing well. 
Forty-eight hours later, a repeat chest X-ray reads “resolved interstitial infiltrates.”




A 55-year-old patient has been ventilated through a tracheostomy in the surgical intensive 
care unit for the past 2 weeks. He develops a fever of 38.5° Celsius (101.3° Fahrenheit). A 
workup is initiated, including blood cultures, urinalysis, and chest X-ray. All are negative. 
He has new moderate secretions and slight rales. A tracheal aspirate is sent, and a Gram 
stain shows many WBCs and few GPCs. The next day, his tracheal aspirate grows many 
Staphylococcus aureus, moderate oral flora, and few yeast.




A 50-year-old patient has been living in a long-term acute care facility and ventilated 
through a tracheostomy for 4 months. He has end-stage renal disease and is dialyzed through 
a tunneled catheter. He is oliguric but urinates through a condom catheter. At the long-term 
acute care facility, he had been complaining of abdominal pain. He presents to your hospital 
for a planned percutaneous gastrostomy tube placement. During the procedure, he had 1 
dose of cefazolin but had no antibiotics afterward. Three days after the procedure, he 
developed a fever of 38.3° centigrade (100.9° Fahrenheit) and a white blood cell count of 15 
cells/μL. He had new diarrhea over the preceding 12 hours, which started after initiating 
tube feeds through his new PEG, and had abdominal pain, which he attributed to the new 
PEG. Prior to this, he had not been on any laxatives and had had normal-consistency bowel 
movements. A C. difficile was sent and was positive. A urinalysis collected via straight 
catheterization showed 2+ leukocyte esterase, too-numerous-to-count white blood cells, and 
moderate bacteria. His urine culture grew 60,000 colony-forming units per milliliter of 
Escherichia coli.
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A 63-year-old woman with non–small cell lung cancer presented with a T5 compression 
fraction and was taken to the OR for a T5 corpectomy and T2–T8 fusion with pedicle screws 
and rods. One week later she became confused, tachycardic, and febrile. Her wound showed 
serosanguinous drainage, but there was no surrounding erythema or pain. She had a foley 
catheter in place for urinary retention and a central line in place for chemotherapy. A 
urinalysis showed many bacteria, moderate white blood cells, and 2+ leukocyte esterase. A 
urine culture grew 50,000 colony-forming units of Pseudomonas. A nonsterile superficial 
swab of the wound grew MRSA. Blood cultures also grew MRSA in 3 of 4 blood cultures 
collected peripherally in 2 sets 2 hours apart. A MRI of her thoracic spine showed a 
superficial fluid collection at the incision.




A 50-year-old woman with end-stage liver disease presented for an orthotopic liver 
transplant. The operation was uneventful, and she was started on immunosuppressing 
medications. She was discharged home 2 weeks after the operation. Five days after 
discharge, she presented to the emergency department complaining of severe abdominal 
pain. She had a fever of 39° centigrade (102.0° Fahrenheit) and was hypotensive with a 
blood pressure of 85/54. Imaging of her abdomen showed a large fluid collection at the 
surgical site. She was taken to the operating room, where purulent fluid was identified 
around the anastomosis. The collection was drained, and she was admitted to the surgical 
intensive care unit. On Gram stain, a sample of the purulent fluid showed many white blood 
cells and many gram-negative rods. The culture grew Escherichia coli. The surgical team 
was concerned for anastamotic breakdown with resulting necrosis.
Does she have an NHSN-defined organ space/surgical site infection?
A. Yes
B. No
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TABLE 1
Respondent Professional Background, Hospital Epidemiology and Infection Control and Prevention 
Department, and Hospital Characteristics, of 113 Total Respondents
Characteristic Value
Title or position (missing = 7)
 Infection preventionist 84 (79.3)
 Hospital epidemiologist 19 (17.9)
 Other 3 (2.8)
CIC or in training (missing = 19) 62 (76.6)
Degree or training (missing = 7)a
 Nursing (RN, BSN, MSN) 62 (58.5)
 Public health, epidemiology, health administration, or policy 36 (34.0)
 Physician (MD, DO) 18 (17.0)
 Medical technology 14 (13.2)
 Microbiology 7 (6.6)
Any clinical background or training (missing = 6) 81 (75.7)
Years in infection prevention, mean ± SD 11.9 ± 8.4
Size of hospital (missing = 9)
 Less than 200 beds 16 (15.4)
 200–499 beds 25 (24.1)
 At least 500 beds 63 (60.6)
Type of hospital (missing = 8)
 Acute care 101 (96.2)
 Not for profit, nongovernmental 81 (77.1)
 State or local governmental 12 (11.4)
 For profit 6 (5.7)
 Federal governmental 6 (5.7)
Teaching hospital (physician, dental, or podiatry residents; missing = 11) 81 (79.4)
Size of infection control and prevention department, mean ± SD (missing = 8) 5.9 ± 3.8
State reporting requirements (missing = 5)b
 Any current state-mandated reporting 89 (82.4)
 SSI 73 (64.6)
 BSI 82 (72.6)
 Pneumonia 18 (15.9)
 Gastrointestinal infection 9 (8.0)
Planned state-reporting requirements (missing = 5)c 6 (5.3)
No current reporting or plan to report healthcare-associated infections 7 (6.2)
NOTE. Data are no. (% of nonmissing responses), unless otherwise indicated. BSI, bloodstream infection; CIC, Certification in Infection Control 
credential; SD, standard deviation; SSI, surgical site infection.
a
For these items, participants were asked to answer yes or no for each individual degree or training option. Missing responses were considered to 
be answers of no. Seven participants did not respond to any items and so were considered to have had missing responses for these items. One 
respondent stated that he or she was a nurse practitioner or physician assistant.
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b
Only 3–6 (2.7%–5.3%) respondents reported other infections, such as bone and joint infection; cardiovascular system infection; eye, ears, nose, 
and throat infection; lower respiratory tract infection; skin and soft-tissue infection; and systemic infection.
c
Included urinary tract infection, SSI, BSI, and pneumonia.
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TABLE 2
Percentages of Correct Responses for Each Clinical Vignette, of 113 Total Respondents
Question Healthcare-associated infection Answering yes Answering no
1 CLABSI (missing = 1) 98 (87.5) 14 (12.5)
2 VAP (missing = 4) 3 (2.8) 106 (97.2)a
3 Tracheobronchitis (missing = 7) 91 (85.8) 15 (14.2)
4 Clostridium difficile (missing = 7) 77 (72.6) 29 (27.4)
5 CLABSI (missing = 1) 48 (42.9) 64 (57.1)
6 Organ space/surgical site infection (missing = 2) 108 (97.3)b 3 (2.7)
 % of correct responses, mean ± SD 61.1 ± 0.96
NOTE. Data are no. (%), unless otherwise indicated. Correct responses were defined as such by a team of National Healthcare Surveillance 
Network experts and are shown in boldface type. CLABSI, central line–associated bloodstream infection; SD, standard deviation; VAP, ventilator-
associated pneumonia.
a
Created as a negative control (ie, intended to be answered with a response of “no, this is not a reportable ventilator-associated pneumonia”).
b
Created as a positive control (ie, intended to be answered with a response of “yes, this is a reportable organ space/surgical site infection”).
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TABLE 3
Associations between Professional Background, Infection Prevention and Control Department, and Hospital 
Characteristics with the Mean Number of Correct Responses
Variable




Job title .18 .11
 Infection preventionist 3.62 ± 0.89
 Hospital epidemiologist 3.95 ± 1.22
Clinical background .063 .044
 Yes (n = 81) 3.78 ± 0.10
 No (n = 26) 3.38 ± 0.18
Infection control and prevention department size .29 .16
 Less than 5 persons (n = 62) 3.60 ± 0.14
 At least 5 persons (n = 43) 3.79 ± 0.11
Hospital size .53 .74
 Less than 500 beds (n = 41) 3.63 ± 1.56
 At least 500 beds (n = 63) 3.75 ± 0.10
Years in infection control and prevention .61 .62
 Less than 5 years (n = 23) 3.65 ± 0.18
 At least 5 years (n = 82) 3.76 ± 0.10
CIC .77 .79
 Yes (n = 62) 3.77 ± 0.11
 No (n = 32) 3.72 ± 0.15
Presence of or plans for state-mandated healthcare-associated infection reporting .071 .55
 Yes (n = 95) 3.71 ± 0.095
 No (n = 18) 3.33 ± 0.28
NOTE. SD, standard deviation.
a
Negative binomial models were used for analyses. Multivariate analyses adjusted for the size of the hospital, presence of a clinical background, 
presence of a Certification in Infection Control (CIC) credential, years of experience in infection control and prevention, size of the infection 
prevention and control department, presence of or plans for state-mandated reporting, and whether the respondent had recorded the name of the 
hospital. Mean number of correct responses in each category (of a possible 6) are presented. P values are for the difference between the 2 groups; 
significance is indicated by boldface type. Analyses are considered statistically significant at α =.05.
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TABLE 4
Associations between Choosing a Particular Response to a Clinical Vignette and the Presence of or Plans for 
State-Mandated Reporting of the Relevant Healthcare-Associated Infection (HAI)
Item no., HAI
Correct responses from states
P
With presence of or plans for 
mandated reporting for the relevant 
HAI
Without plans for mandated 
reporting for the relevant HAI
Question 1, CLABSI (n = 85a) 74 (87.1) 24 (88.9) .80
Question 2, VAP (n = 19a) 18 (94.7) 88 (97.8) .46
Question 3, tracheobronchitis (n = 3a) 3 (100) 88 (85.4) .48
Question 4, Clostridium difficile (n = 8a) 3 (37.5) 98 (26.5) .50
Question 5, CLABSI (n = 85a) 49 (57.6) 15 (55.6) .85
Question 6, organ space/surgical site infection (n = 74a) 73 (98.6) 35 (94.6) .21
NOTE. Data are no. (%). Percentage of correct responses is also presented for responses where reporting of the particular HAI is or is not mandated 
(ie, CLABSI for question 1). Analyses were performed using χ2 tests. No relationships were statistically significant at α =.05. CLABSI, central 
line–associated bloodstream infection; VAP, ventilator-associated pneumonia.
a
Number of respondents in states with plans for or current mandated reporting of that particular HAI.
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